Emkan Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Series A, Series B
Geographical Focus
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Egypt, Tunisia, Libya, Morocco, Algeria, Lebanon, Bahrain, Jordan, Somalia, Iraq, Palestine, Sudan, Mauritania, Yemen, Syria
Industries Focus
- Healthcare
- FinTech
- Logistics
- IT & Technology
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2021
Emkan Capital is a venture capital firm based in Riyadh, Saudi Arabia, specializing in early-stage technology investments across the Middle East and North Africa (MENA) region. The firm focuses on Seed and Series A funding, aiming to mentor and support technology companies to become global players. Emkan Capital's portfolio includes companies like Hubpay, a licensed cross-border remittance solution, and NovoGenomics, a state-of-the-art genetic testing facility. The firm leverages its extensive network and expertise to provide comprehensive support to its portfolio companies, facilitating their growth and success in the global market.
Requirements
- Strong management team
- Innovative technology solutions
- Scalable business models
- Potential for regional and global expansion
- Alignment with MENA market needs
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Hubpay
- NovoGenomics
- InvestSky
Mentioned In
-
$49.95
-
$19.95
-
$9.95
-
$24.95
-
$19.95
-
$19.95
-
$9.95
-
$19.95
Claim this Investor
Are you an official representative of Emkan Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim